Patents by Inventor Stephane Andre Georges Godart

Stephane Andre Georges Godart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • antigenic composition
    Patent number: 10441648
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: October 15, 2019
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • Mycobacterium Antigenic Composition
    Publication number: 20190183998
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 20, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.
    Inventors: Stephane Andre Georges GODART, Amina LAANAN, Dominique Ingrid LEMOINE
  • MYCOBACTERIUM ANTIGENIC COMPOSITION
    Publication number: 20180071378
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: July 6, 2017
    Publication date: March 15, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Stéphane André Georges GODART, Amina LAANAN, Dominique Ingrid LEMOINE
  • antigenic composition
    Patent number: 9730992
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: August 15, 2017
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • Mycobacterium Antigenic Composition
    Publication number: 20160220656
    Abstract: Immunogenic compositions comprising an Rv1196 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: April 18, 2016
    Publication date: August 4, 2016
    Inventors: Stephane Andre Georges GODART, Amina LAANAN, Dominique Ingrid LEMOINE
  • antigenic composition
    Patent number: 9352030
    Abstract: Immunogenic compositions comprising an Rv1196 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: May 31, 2016
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • MYCOBACTERIUM ANTIGENIC COMPOSITION
    Publication number: 20130287809
    Abstract: Immunogenic compositions comprising an Rv1196 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: December 14, 2011
    Publication date: October 31, 2013
    Applicant: GlaxoSmithKline Biologicals s.a.
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • MYCOBACTERIUM ANTIGENIC COMPOSITION
    Publication number: 20130280289
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: December 14, 2011
    Publication date: October 24, 2013
    Applicant: GlaxoSmithKline Biologicals s.a.
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS
    Publication number: 20100215681
    Abstract: The invention provides (a) an HIV Tat protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Nef protein or derivative thereof; or (b) an HIV Nef protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Tat protein or derivative thereof; or (c) an HIV Nef protein or derivative thereof linked to an HIV Tat protein or derivative thereof and a fusion partner. The invention further provides for a nucleic acid encoding such a protein and a host cell, such as Pichia Pastoris, transformed with the aforementioned nucleic acid.
    Type: Application
    Filed: April 26, 2010
    Publication date: August 26, 2010
    Inventors: Claudine BRUCK, Stephane Andre Georges Godart, Martine Marchand
  • FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS
    Publication number: 20090053291
    Abstract: The invention provides (a) an HIV Tat protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Nef protein or derivative thereof; or (b) an HIV Nef protein or derivative thereof linked to either (i) a fusion partner or (ii) an HIV Tat protein or derivative thereof; or (c) an HIV Nef protein or derivative thereof linked to an HIV Tat protein or derivative thereof and a fusion partner. The invention further provides for a nucleic acid encoding such a protein and a host cell, such as Pichia Pastoris, transformed with the aforementioned nucleic acid.
    Type: Application
    Filed: October 30, 2007
    Publication date: February 26, 2009
    Inventors: Claudine BRUCK, Stephane Andre Georges Godart, Martine Marchand